Semi-Annual Consolidated Statement Of Income

Chiome Bioscience Inc. - Filing #7609650

Concept	2022-01-01 to 2022-03-31	2022-01-01 to 2022-03-31	2022-01-01 to 2022-03-31	2022-01-01 to 2022-03-31	2022-01-01 to 2022-03-31	2021-01-01 to 2021-03-31	2021-01-01 to 2021-03-31	2021-01-01 to 2021-03-31	2021-01-01 to 2021-03-31	2021-01-01 to 2021-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales	JPY	128,571,000 JPY	128,571,000 JPY	128,571,000 JPY	JPY	JPY	103,013,000 JPY	143,067,000 JPY	246,081,000 JPY	246,081,000 JPY
Cost of sales	—	—	57,730,000 JPY	—	—	—	—	—	63,879,000 JPY	—
Gross profit (loss)	—	—	70,840,000 JPY	—	—	—	—	—	182,201,000 JPY	—
Ordinary profit (loss)	—	—	-491,189,000 JPY	—	—	—	—	—	-149,640,000 JPY	—
Selling, general and administrative expenses
Selling, general and administrative expenses	—	—	557,361,000 JPY	—	—	—	—	—	337,458,000 JPY	—
Profit (loss) before income taxes	—	—	-491,189,000 JPY	—	—	—	—	—	-149,640,000 JPY	—
Operating profit (loss)	-446,004,000 JPY	70,840,000 JPY	-486,520,000 JPY	-375,163,000 JPY	-111,357,000 JPY	-121,131,000 JPY	-113,415,000 JPY	79,289,000 JPY	-155,257,000 JPY	-34,126,000 JPY
Non-operating income
Interest income	—	—	10,000 JPY	—	—	—	—	—	14,000 JPY	—
Non-operating income	—	—	15,000 JPY	—	—	—	—	—	6,517,000 JPY	—
Income taxes - current	—	—	1,252,000 JPY	—	—	—	—	—	11,064,000 JPY	—
Non-operating expenses
Interest expenses	—	—	321,000 JPY	—	—	—	—	—	313,000 JPY	—
Non-operating expenses	—	—	4,683,000 JPY	—	—	—	—	—	900,000 JPY	—
Income taxes	—	—	1,252,000 JPY	—	—	—	—	—	11,064,000 JPY	—
Profit (loss)	—	—	-492,441,000 JPY	—	—	—	—	—	-160,704,000 JPY	—